Biomarkers, or ‘biological markers’, are used to indicate biological processes by measuring specific characteristics. In this study, biomarkers would ideally be used to inform the medical team to the presence and state of a brain tumour.
The Study and Its Findings
Alongside the Mazumdar Shaw Medical Foundation, a research team at the Centre for Biosystems Science and Engineering has found two blood-based biomarkers on immune cells in the blood with promising qualities.
The team found a high correlation between a specific protein on the cells, and the progression of the individuals tumour. This suggests that measuring these proteins may be a new way to identify the progress and presence of brain tumours.
The team is hopeful that the biomarker proteins can not only identify the presence of a tumour, but also the grade and stage that a tumour is at. This would allow the medical team to act quickly on giving appropriate treatment. It may also present a potential alternative way to diagnose patients.
At this stage however, there needs to be further research to determine if this is a reliable method of providing early information. With future findings, it may be possible for these biomarkers to provide even more information.
To read more scientific information, click here.
If you would like to use your experience and insight to support clinical research, consider signing up to be a PRIME advocate for brainstrust.
If you or someone you love is living with a brain tumour and have any questions around this latest news, or want to access support, give us a call on 01983 292 405 or email firstname.lastname@example.org. You can also visit our little brainstrust website which features support for children affected by brain tumour.